Joint remodelling in inflammatory disease
- PMID: 17934094
- PMCID: PMC2095295
- DOI: 10.1136/ard.2007.078972
Joint remodelling in inflammatory disease
Abstract
Bone and the immune system share multiple interactions. The skeleton harbours the bone marrow and provides the niche for development of haematopoietic cells including the immune system. The immune system provides cells as well as molecular signals, which regulate bone homeostasis. Understanding the cellular and molecular regulation of the tight interaction between bone and the immune system is crucial for understanding the changes of skeletal architecture during inflammation. Whereas a short and self-limited activation of the immune system has no clinically meaningful effect on bone, prolonged immune activation as found in chronic inflammatory disease inevitably leads to bone wasting.
Conflict of interest statement
Competing interests: None declared.
References
-
- Gough A K, Lilley J, Eyre S, Holder R L, Emery P. Generalized bone loss in patients with early rheumatoid arthritis. Lancet 199434423–27. - PubMed
-
- Schett G, Redlich K, Smolen J S. Inflammation‐induced bone loss in the rheumatic diseases. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th edn. USA: Lippincott Williams & Wilkins, 2006310–313.
-
- Firestein G S. Evolving concepts of rheumatoid arthritis. Nature 2003423356–361. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical